coenzyme Q10/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases fasting blood glucose
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Findingreplicated ×1“The administration of CoQ10 resulted in a significant decrease in FBG levels (ESWMD = −5.04, 95% CI: −7.67, −2.40; p < 0.001, I 2 = 58.7%, p = 0.04) (Figure.”
Quoted verbatim from Effects of Coenzyme Q10 Supplementation on Glycemic Control Biomarkers: An Umbrella Review of Meta-Analyses of Randomised Controlled Trials.. - Study
- meta-analysis
- Dose
- 110 to 376.6 mg/day CoQ10 across the included meta-analyses
- Population
- Adults with type 2 diabetes, obesity, polycystic ovary syndrome, chronic kidney disease, metabolic syndrome and other cardiometabolic conditions, from the randomised controlled trials pooled by eight meta-analyses.
Effect -5.04 mean difference, 95% CI -7.67 to -2.4
Effects of Coenzyme Q10 Supplementation on Glycemic Control Biomarkers: An Umbrella Review of Meta-Analyses of Randomised Controlled Trials.2026PMID:41859772Permalink
Keep reading
- Everything the graph holds on coenzyme Q10
- Every compound studied against Fasting blood glucose
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M10B47ZSCVGDYGRQRQSHDFWW